Maastro

Maastricht 10 trials 7 recruiting

10 Registered trials

7 Currently recruiting

Organisation

Maastro

Location

Maastricht, Netherlands

Identifier

ORG-100028273

Address

Dr. Tanslaan 12, 6229 ET, Netherlands

Departments

medical oncology
Radiation Oncology
Radiology
Radiotherapy

Clinical trials at this site (10)

Search interface

A multi-centred, partially randomised, patient-preference trial of radical surgery versus adjuvant chemoradiotherapy after local excision fo… Recruiting

2024-517410-15-01 Rectal cancer 5 2025-01-14
MetAddon: Methadone as co-analgesic for patients with metastatic bone pain: a double-blind randomized controlled trial Recruiting

2025-522710-22-00 Cancer, bone metastasis, pain 6 2026-05-28
Neoadjuvant FOLFOXIRI and Chemoradiotherapy versus Neoadjuvant CAPOX/FOLFOX and Chemoradiotherapy, followed by Surgery or a Watch-and-Wait A… Recruiting

2025-523692-39-00 locally advanced rectal cancer 5 2026-03-11
PREOPANC-5 Recruiting

2023-508707-20-00 Borderline resectable pancreatic cancer (BRPC) 9 2024-09-19
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials (MMRd-GREEN) Recruiting

2023-503267-42-00 Patients with a histological diagnosis of mismatch- rep 5 2022-06-10
The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: a randomized multi-center study in resectable HER2… Recruiting

2024-513797-22-00 HER2 positive esophageal adenocarcinoma 5 2022-03-09
Multicentre, open-label, randomized, controlled, parallel arms clinical trial of induction chemotherapy followed by chemoradiotherapy versus… Recruiting

2024-512526-28-00 Locally recurrent rectal cancer 5 2020-10-28
Comparison of targeted radiotherapy with and without short-term hormonal treatment (6 months) Ended

2024-511252-41-00 Patients with biochemical recurrence after primary trea 5 2024-07-30
Induction chemotherapy for locally advanced rectal cancer. Ended

2023-509758-74-00 Locally advanced rectal cancer 4 2021-07-21
CRITICS-II Ended

2023-503248-15-00 Patients with TNM 8th ed stage IB-IIC gastric adenocaci 4 2017-10-09